NBD AI Bulletin，Guangzhou KingMed Diagnostics Group Co., Ltd. (the Company, SH 603882, closing price: 79.15 yuan) announced on the evening of Thursday that its shareholder Shanghai Chende Weijing Investment Center (Limited Partnership) (referred to as Chende Weijing) unloaded 520,000 shares of the Company from March 4, 2020 to June 3, 2020 at 60-76.6 yuan each, accounting for 0.11% of the Company's total shares. After the sale, shareholder Chende Weijing holds about 2.58 million shares (0.56%) of the Company.
According to its 2019 annual report, Guangzhou KingMed Diagnostics Group Co., Ltd.'s main business is third-party medical diagnostics, accounting for 94.22% of its revenue.
Guangzhou KingMed Diagnostics Group Co., Ltd.'s chairman and general manager is Liang Yaoming, a 56-years-old MBA holder with no permanent residence abroad.
(By Tan Yuhan)
Disclaimer: This article is for informational purposes only and does Not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.